Benzoxazine isoquinolines as M4 selective muscarinic receptor antagonists

被引：0
|
作者：
Schwarz, RD
Boehme, TM
Augelli-Szafran, CE
Moreland, DW
机构：
[1] Pfizer Global Res & Dev, Ann Arbor Labs, Dept Neurosci Therapeut, Ann Arbor, MI USA
[2] Pfizer Global Res & Dev, Ann Arbor Labs, Dept Med Chem, Ann Arbor, MI USA
来源：
LIFE SCIENCES | 2001年 / 68卷 / 22-23期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
23
引用
收藏
页码：2626 / 2626
页数：1
相关论文
共 50 条
  • [21] Optimization and identification of brain penetrant, M4 subtype-selective muscarinic receptor positive allosteric modulator (M4 PAM) clinical candidate
    Butler, Christopher
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [22] THE DISTINCT PHARMACOLOGICAL PROFILE OF EMRACLIDINE, A SELECTIVE POSITIVE ALLOSTERIC MODULATOR OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR
    Klein, Ellie
    Quinn, Angela
    Toh, May Fern
    Te, Leonard
    Catipay, Gwyneth
    Smith, Deborah L.
    Gupta, Kushali
    Hatch, Jamie
    Hanh Nguyen
    Iredale, Philip
    Pin, Sokhom
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 541 - 542
  • [23] Structure activity relationships of 7-azaindolines as selective M4 muscarinic acetylcholine receptor agonists
    Suwa, Atsushi
    Sumiyoshi, Takaaki
    Takai, Kentaro
    Konishi, Yasuko
    Uruno, Yoshiharu
    Ochi, Yoshiaki
    Enomoto, Takeshi
    Matsuda, Harumi
    Sakai, Mutsuko
    Nakako, Tomokazu
    Kiyoshi, Akihiko
    Uematsu, Yasuaki
    Kitamura, Atsushi
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [24] Muscarinic toxin selective for m4 receptors impairs memory in the rat
    Jerusalinsky, D
    Kornisiuk, E
    Alfaro, P
    Quillfeldt, J
    Alonso, M
    Verde, ER
    Cerveñansky, C
    Harvey, A
    NEUROREPORT, 1998, 9 (07) : 1407 - 1411
  • [25] Characterization of novel selective positive allosteric modulators (PAMs) of the M4 muscarinic acetylcholine receptor (mAChR)
    Brady, Ashley Elizabeth
    Bridges, Tom M.
    Jones, Carrie K.
    Shirey, Jana K.
    Lindsley, Craig W.
    Conn, P. Jeffrey
    FASEB JOURNAL, 2008, 22
  • [26] Selective muscarinic receptor agonists and antagonists
    Eglen, RM
    Watson, N
    PHARMACOLOGY & TOXICOLOGY, 1996, 78 (02): : 59 - 68
  • [27] Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia
    Chan, W. Y.
    McKinzie, D. L.
    Bose, S.
    Mitchell, S. N.
    Witkin, J. M.
    Thompson, R. C.
    Christopoulos, A.
    Lazareno, S.
    Birdsall, N. J. M.
    Bymaster, F. P.
    Felder, C. C.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (31) : 10978 - 10983
  • [28] Identification and characterization of m1 selective muscarinic receptor antagonists
    Augelli-Szafran, CE
    Blankley, CJ
    Jaen, JC
    Moreland, DW
    Nelson, CB
    Penvose-Yi, JR
    Schwarz, RD
    Thomas, AJ
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (03) : 356 - 363
  • [29] Diphenyl sulfoxides as selective antagonists of the muscarinic M2 receptor
    Kozlowski, JA
    Lowe, DB
    Guzik, HS
    Zhou, GW
    Ruperto, VB
    Duffy, RA
    McQuade, R
    Crosby, G
    Taylor, LA
    Billard, W
    Binch, H
    Lachowicz, JE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (20) : 2255 - 2257
  • [30] The muscarinic M4 acetylcholine receptor exacerbates symptoms of movement disorders
    Chambers, Nicole E.
    Millett, Michael
    Moehle, Mark S.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2023, 51 (02) : 691 - 702
12345